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ical, hematopoietic and metabolic tasks that result from the close 
interaction between the osteoblast and the osteoclast. Bone emerged 
lately as an endocrine organ controlling the metabolism of glucose. 
More recently, a special attention has been focused on the os-
teoblasts, osteoclasts and osteocytes functions in people with dia-
betes. Some complications of DM may lead to osteoporotic fractures. 
People affected with type 2 DM have increased fracture risk despite 
higher bone mineral density (BMD), as shown by trabecular bone 
score (TBS) and micro indentation of the tibia tests. Type 2 DM also 
results in an increased risk of fracture and delayed fracture healing. 
Since some years ago, some medications for type 2 diabetes were 
associated with an increase in bone fractures. Poor glycemic control 
in type 2 diabetes is associated with increased risk of fragility frac-
tures. Increased longevity and a lifestyle characterized by low phys-
ical activity and high-energy food intake contribute to an increasing 
incidence of DM and osteoporosis. Both osteoporosis and DM have 
high social and financial costs. Hospital inpatient care, medication 
and supplies, retail prescriptions to treat complications, physician 
office visits and paramedical social assistance have high expendi-
tures. The risk for precocious death among those with diabetes is 
about twice that of people with similar age but without diabetes. So, 
these important public health problems, DM and osteoporosis, are 
two of the leading causes of death. Thus, the bone tissue needs to be 
recognized as another important target among the late diabetic 
complications.
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Introduction: Worldwide, osteoporosis and resulting fractures 
constitute a major public health burden with often devastating con-
sequences, leading to increased levels of morbidity and mortality. 
Determination of molecular genetic causes of osteoporosis is a per-
spective approach. There are several methodologies to assess the 
contribution of a candidate gene in the pathogenesis of osteoporosis. 
One of them consists in determining the correlation between allelic 
polymorphism and candidate factors which cause the disease, which 
in comparison estimates allele frequencies of candidate genes in os-
teoporosis patients with individuals not having the disease and pre-
serving normal bone mineral density.
Objectives: To determine the alleles frequency of genes. regula-
tors of bone metabolism in patients with osteoporosis in Ukrainian 
population, and to assess the contribution of different polymor-
phisms in the risk of developing the disease.
Methods: DNA extraction was performed using the phenol-chlo-
roform method from whole blood. Using PCR followed by restriction 
digestion and visualization of the reaction products in polyacryl-
amide gel have been studied 180 patients with osteoporosis and 
160 healthy people of the same age.
Results: We have found association of polymorphism 60890 A/G 
of vitamin D receptor gene (OR = 3.2 (CI95% 2.2-4.6)) and -234 T/G 
polymorphism of collagen type 1 gene (OR = 2.8 (CI95% 2.1-4.1)) with 
the risk of osteoporosis developing. We have not found association 
of polymorphism -764 T/G of estrogen receptor gene (OR = 1,2 (CI95% 
0.6-2.3)).
Conclusions: Knowing association between pathogenic alleles, 
candidate genes and osteoporosis in Ukrainian population will allow 
to use genetic testing to identify predisposition to the disease. The 
results of this study are important for a more rational organization 
of the prevention and treatment of the illness in the early stages of 
disease development.
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Introduction: Several cardiovascular diseases (hypertension di-
abetes, atherosclerosis, heart failure, and chronic kidney diseases) 
have physiopathology pathways in common with osteoporosis.
Objectives: To evaluate the genetic variation in those pathways 
in association studies of osteoporosis.
Methods: The evaluation of osteoporosis and obesity was done in 650 
subjects after measurement of anthropometric parameters like BMI 
(Kg/m2) and BMD (g/cm2) by DEXA. For the stratification of BMD, densi-
tometry was evaluated with QDR Discovery W and the respective soft-
ware 12.02 (Hologic Inc). Genotyping was performed for SNPs, Ins/Del 
and CNVs with PCR, PCR/RFLPs and PAGE technics. Statistics test were 
done with the used of SPSS programme. The analyses of continuous pa-
rameters and discrete data were employed with the appropriate tests.
Results: We studied variation in genes coding proteins belonging 
to acute phase subsystems (Renin–Angiotensin, Haptoglobin-HFE), 
hormonal systems (CYP1A1-COMT), neurotransmitters (5HTLPR, 
5HTVNTR), transducing signals (ACP1 or LMWPTP) and metabolic 
pathways (MTHFR, GSTM and GSTT).
Conclusions: We observed some involvement of those genetic 
polymorphisms in the susceptibility to osteoporosis and its relation-
ship with the metabolic syndrome, not only of individual genes but 
also for epistasis between them.
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Introduction: Several studies discuss the relationship between 
systemic bone mineral density (BMD) and periodontal diseases. Os-
teoporosis or low systemic BMD should be considered as the risk 
factor for periodontal disease progression.
Objectives: The purpose of this study was to determine the im-
pact of bone metabolism – bone formation, on the periodontal status 
in the patients.
Methods: The study included 72 patients (42 men and 30 women, 
mean age – 45.3 ± 6.2 years) with the healthy periodontal status 
(HPS) and 253 patients (145 men and 108 women, mean age – 45.6 ± 
5.2 years) with generalized periodontitis (GP). Clinical conditions of 
periodontal tissue and radiographic determinations (panoramic 
X-Ray) were evaluated. Skeletal systemic BMD was measured by 
DXA. Metabolic processes of bone tissue were evaluated by bone 
turnover markers: bone tissue formation – osteocalcin (OC), 
bone-specific alkaline phosphatase (BAP) in serum.
Results: Comparative analysis of structural and functional state of 
bone tissue in patients showed a mineral density reduction in GP group 
compared to HPS, but these changes were not statistically significant. 
Disorders of bone tissue metabolism were determined in patients with 
GP. The OC level in the patients with GP (18.89 ± 0.87 ng/ml in men and 
20.39 ± 1.14 ng/ml in women) was statistically significantly (p < 0.01) 
lower compared to the HPS group (24.14 ± 1.04 ng/ml in men and 27.56 
± 1.12 ng/ml in women). Decreased levels of bone formation of biochem-
ical bone remodeling markers (BAP) were found in men (19.21 ± 1,76 U/l) 
and women (22.31 ± 1.65 U/l) GP compared to HPS (25. 21 ± 1.76 U/l in 
men and 29,17 ± 1,13 U/l in women, p < 0.05)
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Conclusions: These results suggest that periodontitis associations 
with bone metabolic disturbances. In patients with periodontitis un-
balanced bone remodeling was found: decreased bone formation. The 
results suggest the necessity to correct bone tissue metabolism in pa-
tients with generalized periodontitis by osteotropic medications.
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Introduction: Patients with chronic kidney disease (CKD) fre-
quently have disturbances in mineral metabolism, abnormalities in 
vitamin D. parathyroid hormone (PTH) homeostasis and bone disor-
ders, known as CKD- MBD.
Objectives: To study the prevalence of bone and mineral metab-
olism disorders in patients with various stages of CKD.
Methods: We analyzed data on 220 adults with CKD aged 20- 
61 years. 78 (35.5%) patients with CKD II-IV stages and 142 (64.5%) 
patients on hemodialysis (CKD VD). BMD was measured using DEXA 
in L1-L4 segment and femoral neck. The laboratory investigations 
included PTH, vitamin D, calcium (Ca), phosphate (P) serum concen-
trations.
Results: The concentrations of Ca × P product and PTH were sig-
nificantly higher in hemodialysis patients compared to CKD stages 
II-IV ones (Ca × P product 4.78 ± 0.11 vs 3.68 ± 0.18, p < 0.01, iPTH 
601.28 ± 68.45 vs 289.10 ± 60.48 p < 0.01). Analyzing the compliance 
with KDIGO 2011 recommendations it was found that all four param-
eters met target levels of only in 14.1% patients with CKD II-IV stages 
and 3% with CKD VD stage. Vitamin D insufficiency was found in 
44.9% of CKD II-IV patients and 51.4% those with CKD VD. BMD was 
decreased in 55.4% CKD II-IV stages patients and in 19.1% it was lower 
than -2.5 T SD. In CKD VD BMD was decreased in 51.1% and in 34.0% 
it was lower than -2.5 T SD. Negative association between decreased 
renal function and decreased BMD was established: GFR correlated 
s with spine-BMD (r = -0.452, p < 0.05).
Conclusions: In CKD patients dominant disorders of mineral me-
tabolism are hyperphosphatemia, secondary hyperpathyroidism and 
25 (OH) D3 insufficiency. They occur in the early stages of CKD and 
progress with the decline of renal function, especially in hemodial-
ysis and result in bone loss.
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Introduction: Many factors can cause wrong results and incor-
rect interpretations in DXA. Assuming that a quality control program 
of the equipment is working, the causes rely mainly in the patient or 
in the interpretation.
Objectives: Identifying causes of reanalysis and repetition of DXA 
analysis in an outpatient practice.
Methods: We reviewed all the DXA examinations done in 
6185 patients, made in 2 sites, with LUNAR DPX equipments, by a 
team of 12 technologists. Examinations were reported by two con-
sultant radiologists (and also certified clinical densitometrists). Cor-
relation with other imaging modalities (X-ray, CT, MR) was available 
on PACS in many cases.
Results: Being this poster a pictorial assay, the total number of 
cases or the full distribution are not relevant. We will present the 
more frequent identified errors and other rare ones: errors in data 
introduction, patient artefacts, anatomy variants, deficient position 
and coexisting diseases or therapeutic instrumentations (and not 
forgetting analysis mistakes...) The main objective in this presenta-
tion is to learn with our mistakes.
Conclusions: Particular care in checking that patient has really 
removed all artefacts and that hasn’t done (or is going to make) an-
other imaging technique. Don’t rely in equipment anatomical detec-
tion. Any abnormal discrepancy should be checked and eventually 
additional X-ray image be done. We hope that this pictorial assay can 
help reduce the number of second examinations and difficult inter-
pretations and alert to potential error situations.
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Objectives: The aim of the study was to evaluate the Bone Min-
eral Density (BMD), Trabecular Bone Score (TBS) and the 10-year 
probability of major osteoporotic fracture and hip fracture in healthy 
men of different ages.
Methods: We’ve examined 300 men aged 40-89 years. They were 
divided into groups depending on their age: 40-49 yrs (n = 52), 50-
59 yrs (n = 86), 60-69 yrs (n = 89), 70-79 yrs (n = 59), 80-89 yrs (n = 14). 
The 10-year probability of hip fracture and the 10-year probability of 
major osteoporotic fracture risk were calculated by Austrian, Polish 
and Russian FRAX® models. BMD of whole body, PA lumbar spine and 
proximal femur were measured by DXA method (Prodigy, Lunar) and 
PA spine TBS were assessed by TBS iNsight® software package in-
stalled on the available DXA machine (Med-Imaps, Pessac, France).
Results: We have observed a significant increase of 10-year prob-
ability of major osteoporotic fracture in men aged 80-89 yrs (p 
< 0.01) by Russian FRAX® model, 60-89 yrs (p < 0.01) – Austrian 
FRAX® model, 70-89 yrs (p < 0.01) – Polish FRAX® model in compar-
ison with men aged 40-49 yrs. 10-year probability of hip fracture 
was significantly increased in men aged 70-89 yrs in comparison 
with men aged 40-69 yrs (p < 0.01). It was determined the significant 
decreasing of TBS in men according to their age (40-49 yrs – 1.116 ± 
0.02, 50-59 yrs – 1.111 ± 0.02; 60-69 yrs – 1.118 ± 0.02; 70-79 yrs. 
1.062 ± 0.02, 80-89 yrs – 1.080 ± 0.05; F = 2.42, p = 0.048). TBS in men 
was significantly higher in subject with normal BMD (1.121 ± 0.01) 
compared with patient who osteoporosis – 1.066 ± 0.03 (p = 0.04). 
The significant correlation was observed between TBS and BMD L1-
L4 in examined men (r = 0.12; p = 0.03). There wasn’t any correlation 
between TBS and BMD of femoral neck.
Conclusions: TBS significantly decreased with ageing. Subjects 
with osteoporosis have significantly lower TBS compared with nor-
mal BMD examined. It was found a significant correlation between 
TBS and BMD L1-L4.
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The bone strength is mostly dependent on bone mineral density 
and microarchitecture (quality). The BMD by DXA scan is the gold 
